VASCULITIS

You have access
Mortality among Patients with Giant Cell Arteritis: A Large-scale Population-based Cohort Study
Niv Ben-Shabat, Shmuel Tiosano, Ora Shovman, Doron Comaneshter, Yehuda Shoenfeld, Arnon D. Cohen and Howard Amital

The Journal of Rheumatology September 1 2020, 47 (9) 1385-1391; DOI: https://doi.org/10.3899/jrheum.190927
You have access
Malignancies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: A Population-based Cohort Study
Caroline Heijl, Kerstin Westman, Peter Höglund and Aladdin J. Mohammad

The Journal of Rheumatology August 1 2020, 47 (8) 1229-1237; DOI: https://doi.org/10.3899/jrheum.181438
You have access
Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis
Alicia Rodriguez-Pla, Roscoe L. Warner, David Cuthbertson, Simon Carette, Nader A. Khalidi, Curry L. Koening, Carol A. Langford, Carol A. McAlear, Larry W. Moreland, Christian Pagnoux, Philip Seo, Ulrich Specks, Antoine G. Sreih, Steven R. Ytterberg, Kent J. Johnson, Peter A. Merkel and Paul A. Monach for the Vasculitis Clinical Research Consortium

The Journal of Rheumatology July 1 2020, 47 (7) 1001-1010; DOI: https://doi.org/10.3899/jrheum.190093
You have access
Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome
Anne Claire Desbois, Lucie Biard, Damien Sène, Isabelle Brocheriou, Philippe Rouvier, Bertrand Lioger, Lucile Musset, Sophie Candon, Thierry Zenone, Matthieu Resche-Rigon, Jean-Charles Piette, Neila Benameur, Patrice Cacoub and David Saadoun

The Journal of Rheumatology June 1 2020, 47 (6) 896-902; DOI: https://doi.org/10.3899/jrheum.190076
You have access
Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls
Lene Kristin Brekke, Bjørg-Tilde Svanes Fevang, Andreas P. Diamantopoulos, Jörg Assmus, Elisabet Esperø and Clara Gram Gjesdal

The Journal of Rheumatology May 1 2020, 47 (5) 722-729; DOI: https://doi.org/10.3899/jrheum.190147
You have access
Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events
Caitrin M. Coffey, Michael D. Richter, Cynthia S. Crowson, Matthew J. Koster, Kenneth J. Warrington, Steven R. Ytterberg and Ashima Makol

The Journal of Rheumatology April 1 2020, 47 (4) 518-523; DOI: https://doi.org/10.3899/jrheum.181397
You have access
Malignancies in Giant Cell Arteritis: A Population-based Cohort Study
Pavlos Stamatis, Carl Turesson, Minna Willim, Jan-Åke Nilsson, Martin Englund and Aladdin J. Mohammad

The Journal of Rheumatology March 1 2020, 47 (3) 400-406; DOI: https://doi.org/10.3899/jrheum.190236
You have access
Prevalence and Risk Factors for Major Infections in Patients with Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Influence on the Disease Outcome
Eloi Garcia-Vives, Alfons Segarra-Medrano, Ferran Martinez-Valle, Irene Agraz and Roser Solans-Laque

The Journal of Rheumatology March 1 2020, 47 (3) 407-414; DOI: https://doi.org/10.3899/jrheum.190065
Open Access
Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist
Shahin Jamal, Marie Hudson, Aurore Fifi-Mah and Carrie Ye

The Journal of Rheumatology February 1 2020, 47 (2) 166-175; DOI: https://doi.org/10.3899/jrheum.190084
You have access
Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis
Shubhasree Banerjee, Kaitlin A. Quinn, K. Bates Gribbons, Joel S. Rosenblum, Ali Cahid Civelek, Elaine Novakovich, Peter A. Merkel, Mark A. Ahlman and Peter C. Grayson

The Journal of Rheumatology January 1 2020, 47 (1) 99-107; DOI: https://doi.org/10.3899/jrheum.181222

Main menu

User menu

Search

VASCULITIS

Pages

Content

Resources

Subscribers

More